Article info

Download PDFPDF
Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
  1. Correspondence to: MrJohn L Hungerford FRCS, Department of Ophthalmology, Ocular Oncology Service, St Bartholomew’s Hospital, West Smithfield, London EC1A 7BE, UK; paulcauchi{at}doctors.org.uk
View Full Text

Citation

Gombos DS, Cauchi PA, Hungerford JL, et al
Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

Publication history

  • Accepted April 24, 2006
  • First published May 17, 2006.
Online issue publication 
August 23, 2006

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.